ethylenediamine has been researched along with fosbretabulin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambardekar, VV; Bathena, SP; Curran, SM; Dong, Y; Gautam, N; Simet, SM; Singh, RK; Tallapaka, SB; Thakare, R; Vetro, JA; Wakaskar, RR | 1 |
1 other study(ies) available for ethylenediamine and fosbretabulin
| Article | Year |
|---|---|
Peripherally cross-linking the shell of core-shell polymer micelles decreases premature release of physically loaded combretastatin A4 in whole blood and increases its mean residence time and subsequent potency against primary murine breast tumors after I
Topics: Administration, Intravenous; Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cells, Cultured; Chemistry, Pharmaceutical; Cross-Linking Reagents; Dose-Response Relationship, Drug; Drug Carriers; Ethylenediamines; Feasibility Studies; Female; Human Umbilical Vein Endothelial Cells; Humans; Hydrophobic and Hydrophilic Interactions; Mice; Mice, Inbred BALB C; Micelles; Poloxamer; Solubility; Stilbenes; Technology, Pharmaceutical | 2015 |